For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...
Why is old exon science getting new traction? What’s unsettling biotech VCs? And who will be the next CEO of PhRMA?
Industry layoffs continue to accelerate, this time hitting RA Capital’s biotech incubator, according to Stat. RA Ventures, also known as Raven, is a healthcare accelerator for the prominent life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results